Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 9.8B | 10.1B | 9.7B | 9.6B |
| Cost of revenue | 6.0B | 6.4B | 6.0B | 5.9B |
| Gross profit | 3.8B | 3.7B | 3.7B | 3.7B |
| Operating expense | ||||
| Research & development | 439M | 426M | 368M | 382M |
| Selling general and admin | 1.4B | 1.4B | 1.4B | 1.4B |
| Other operating expenses | — | — | — | — |
| Operating income | 2.0B | 1.8B | 2.0B | 2.0B |
| Non operating interest income | ||||
| Income | 90M | 101M | 110M | 110M |
| Expense | 286M | 291M | 297M | 250M |
| Other income expense | 95M | -105M | 28M | 136M |
| Pretax income | 1.9B | 1.5B | 1.8B | 2.0B |
| Tax provision | 417M | 254M | 409M | 414M |
| Net income | 1.5B | 1.3B | 1.4B | 1.6B |
| Basic EPS | 2.2 | 2.0 | 2.2 | 2.4 |
| Diluted EPS | 2.2 | 2.0 | 2.2 | 2.4 |
| Basic average shares | 648.2M | 650.6M | 650.4M | 650.2M |
| Diluted average shares | 651.7M | 654.8M | 654.1M | 654.2M |
| EBITDA | 2.6B | 2.3B | 2.6B | 2.6B |
| Net income from continuing op. | 1.5B | 1.3B | 1.4B | 1.6B |
| Minority interests | -18M | -5M | -2M | -16M |
| Preferred stock dividends | — | — | — | — |